vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and SunOpta Inc. (STKL). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $205.4M, roughly 1.0× SunOpta Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 0.4%, a 57.0% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $12.1M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
SunOpta, Inc. is a multi-national food and mineral company headquartered in Eden Prairie, Minnesota and founded in 1973 in Canada.
IDYA vs STKL — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $205.4M |
| Net Profit | $119.2M | $816.0K |
| Gross Margin | — | 12.4% |
| Operating Margin | 52.2% | 3.3% |
| Net Margin | 57.4% | 0.4% |
| Revenue YoY | — | 16.6% |
| Net Profit YoY | 330.1% | 113.1% |
| EPS (diluted) | $1.33 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $207.8M | $205.4M | ||
| Q2 25 | — | $191.5M | ||
| Q1 25 | — | $201.6M | ||
| Q4 24 | — | $193.9M | ||
| Q3 24 | $0 | $175.9M | ||
| Q2 24 | $0 | $169.5M | ||
| Q1 24 | $0 | $184.4M | ||
| Q4 23 | — | $178.1M |
| Q3 25 | $119.2M | $816.0K | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $4.8M | ||
| Q4 24 | — | $-8.7M | ||
| Q3 24 | $-51.8M | $-6.2M | ||
| Q2 24 | $-52.8M | $-5.3M | ||
| Q1 24 | $-39.6M | $2.9M | ||
| Q4 23 | — | $-15.5M |
| Q3 25 | — | 12.4% | ||
| Q2 25 | — | 14.8% | ||
| Q1 25 | — | 15.0% | ||
| Q4 24 | — | 10.9% | ||
| Q3 24 | — | 13.0% | ||
| Q2 24 | — | 12.5% | ||
| Q1 24 | — | 16.8% | ||
| Q4 23 | — | 14.1% |
| Q3 25 | 52.2% | 3.3% | ||
| Q2 25 | — | 5.5% | ||
| Q1 25 | — | 5.2% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 5.5% | ||
| Q4 23 | — | 2.1% |
| Q3 25 | 57.4% | 0.4% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | -4.5% | ||
| Q3 24 | — | -3.5% | ||
| Q2 24 | — | -3.1% | ||
| Q1 24 | — | 1.6% | ||
| Q4 23 | — | -8.7% |
| Q3 25 | $1.33 | $0.01 | ||
| Q2 25 | — | $0.03 | ||
| Q1 25 | — | $0.04 | ||
| Q4 24 | — | $-0.08 | ||
| Q3 24 | $-0.60 | $-0.05 | ||
| Q2 24 | $-0.68 | $-0.04 | ||
| Q1 24 | $-0.53 | $0.02 | ||
| Q4 23 | — | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $2.2M |
| Total DebtLower is stronger | — | $250.8M |
| Stockholders' EquityBook value | $1.1B | $162.8M |
| Total Assets | $1.2B | $694.1M |
| Debt / EquityLower = less leverage | — | 1.54× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $786.9M | $2.2M | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | $920.0M | $2.9M | ||
| Q2 24 | $701.7M | $3.2M | ||
| Q1 24 | $698.8M | $1.5M | ||
| Q4 23 | — | $306.0K |
| Q3 25 | — | $250.8M | ||
| Q2 25 | — | $263.3M | ||
| Q1 25 | — | $260.6M | ||
| Q4 24 | — | $265.2M | ||
| Q3 24 | — | $289.9M | ||
| Q2 24 | — | $303.1M | ||
| Q1 24 | — | $258.8M | ||
| Q4 23 | — | $263.5M |
| Q3 25 | $1.1B | $162.8M | ||
| Q2 25 | — | $159.8M | ||
| Q1 25 | — | $154.8M | ||
| Q4 24 | — | $148.6M | ||
| Q3 24 | $1.2B | $155.0M | ||
| Q2 24 | $931.7M | $158.8M | ||
| Q1 24 | $935.3M | $163.6M | ||
| Q4 23 | — | $156.3M |
| Q3 25 | $1.2B | $694.1M | ||
| Q2 25 | — | $704.9M | ||
| Q1 25 | — | $690.7M | ||
| Q4 24 | — | $668.5M | ||
| Q3 24 | $1.2B | $699.3M | ||
| Q2 24 | $973.7M | $704.7M | ||
| Q1 24 | $961.5M | $671.8M | ||
| Q4 23 | — | $667.2M |
| Q3 25 | — | 1.54× | ||
| Q2 25 | — | 1.65× | ||
| Q1 25 | — | 1.68× | ||
| Q4 24 | — | 1.78× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | — | 1.91× | ||
| Q1 24 | — | 1.58× | ||
| Q4 23 | — | 1.69× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $16.3M |
| Free Cash FlowOCF − Capex | $142.2M | $12.1M |
| FCF MarginFCF / Revenue | 68.4% | 5.9% |
| Capex IntensityCapex / Revenue | 0.0% | 2.1% |
| Cash ConversionOCF / Net Profit | 1.19× | 20.03× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $36.4M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $142.2M | $16.3M | ||
| Q2 25 | — | $-4.5M | ||
| Q1 25 | — | $22.3M | ||
| Q4 24 | — | $33.1M | ||
| Q3 24 | $-49.2M | $17.2M | ||
| Q2 24 | $-32.9M | $-5.6M | ||
| Q1 24 | $-43.8M | $5.3M | ||
| Q4 23 | — | $4.4M |
| Q3 25 | $142.2M | $12.1M | ||
| Q2 25 | — | $-9.2M | ||
| Q1 25 | — | $9.5M | ||
| Q4 24 | — | $24.0M | ||
| Q3 24 | $-49.7M | $11.7M | ||
| Q2 24 | $-33.9M | $-15.3M | ||
| Q1 24 | $-45.1M | $-2.3M | ||
| Q4 23 | — | $-3.5M |
| Q3 25 | 68.4% | 5.9% | ||
| Q2 25 | — | -4.8% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | — | 6.6% | ||
| Q2 24 | — | -9.0% | ||
| Q1 24 | — | -1.2% | ||
| Q4 23 | — | -2.0% |
| Q3 25 | 0.0% | 2.1% | ||
| Q2 25 | — | 2.5% | ||
| Q1 25 | — | 6.3% | ||
| Q4 24 | — | 4.7% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | 4.1% | ||
| Q4 23 | — | 4.5% |
| Q3 25 | 1.19× | 20.03× | ||
| Q2 25 | — | -1.03× | ||
| Q1 25 | — | 4.63× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.83× | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
STKL
| Beverages And Broths | $161.4M | 79% |
| Fruit Snacks | $40.9M | 20% |
| Ingredients | $3.1M | 2% |
